伊卡林通过RSK2驱动的YAP-cGAS-IFN-β信号激活来拯救败血症中的免疫功能障碍
Yuran Huang1, Fupeng Wu2, Tianle Zhan3
1Department of Pharmacology, School of Pharmaceutical Sciences & Minhang Hospital, Fudan University, Shanghai, 201203, China.
概括
伊卡林 (ICA) 通过增强抗菌免疫力来对抗败血症引起的免疫抑制. 这种天然化合物向RSK2-YAP-cGAS-IFN-β通路,具有治疗二次感染的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 败血症经常引发免疫抑制,增加死亡率和二次感染风险.
- 伊卡林 (ICA) 显示生物活性,但其对败血症引起的免疫抑制的影响尚不清楚.
研究的目的:
- 为了研究Icariin对败血症诱导的免疫抑制的治疗潜力.
- 阐明Icariin作用背后的分子机制.
主要方法:
- 使用了一种具有二次感染的败血症小鼠模型 (CLP接着是Pseudomonas aeruginosa挑战) 和一个体外内毒素耐受性巨模型.
- 给小鼠注射伊卡林,评估了包括生存,器官损伤,细菌负载和巨细胞两极分化在内的结果.
- 在体外测试中检查了巨细胞化,杀死细菌和分子通路,使用技术如qPCR和Western blot.
主要成果:
- 伊卡里因显著改善了生存率,减少了器官损伤和细菌负载,并将巨细胞的两极分化转向M1表型.
- 在体外,Icariin增强了巨细胞的菌和杀菌功能.
- 从机制上讲,Icariin针对RSK2,导致YAP降解,减少cGAS抑制,并通过TBK1-IRF3通路对IFN-β进行上调.
结论:
- 伊卡里因有效地缓解败血症引起的免疫抑制,并增强抗菌免疫力.
- 该研究确定RSK2-YAP-cGAS-IFN-β通路对于Icariin的治疗效果至关重要.
- 伊卡林在治疗败血症后的二次感染方面显示出显著的治疗潜力.
相关概念视频
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K


